Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Evoke Pharma (EVOK) Inventory Average (2020 - 2025)

Historic Inventory Average for Evoke Pharma (EVOK) over the last 6 years, with Q3 2025 value amounting to $620890.0.

  • Evoke Pharma's Inventory Average rose 1961.2% to $620890.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $620890.0, marking a year-over-year increase of 1961.2%. This contributed to the annual value of $463460.5 for FY2024, which is 2018.92% up from last year.
  • As of Q3 2025, Evoke Pharma's Inventory Average stood at $620890.0, which was up 1961.2% from $587008.5 recorded in Q2 2025.
  • In the past 5 years, Evoke Pharma's Inventory Average registered a high of $620890.0 during Q3 2025, and its lowest value of $205375.5 during Q4 2021.
  • Over the past 5 years, Evoke Pharma's median Inventory Average value was $439289.5 (recorded in 2023), while the average stood at $393011.2.
  • As far as peak fluctuations go, Evoke Pharma's Inventory Average surged by 10846.45% in 2023, and later tumbled by 872.3% in 2025.
  • Evoke Pharma's Inventory Average (Quarter) stood at $205375.5 in 2021, then rose by 24.09% to $254841.0 in 2022, then surged by 93.6% to $493382.5 in 2023, then decreased by 4.89% to $469244.5 in 2024, then surged by 32.32% to $620890.0 in 2025.
  • Its Inventory Average was $620890.0 in Q3 2025, compared to $587008.5 in Q2 2025 and $488613.0 in Q1 2025.